FDA's Sentinel Initiative - Pharmacovigilance 2020

Danijela Stojanovic and Monica Muñoz from CDER’s Office of Surveillance and Epidemiology (OSE) provide an overview of FDA’s Sentinel Initiative, to include the Active Post-market Risk Identification and Analysis System (ARIA) and its application. They also describe the approach towards building signal identification capabilities in Sentinel.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia

CDER SBIA 2020 Playlist:    • 2020 CDER Small Business and Industry...  
LinkedIn:   / cder-small-business-and-industry-assistance  
Training resources: https://www.fda.gov/cderbsbialearn

Twitter:   / fda_drug_info  

CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...

Email: [email protected]
Phone: (301) 796-6707 I (866) 405-5367